Gene · 835
Papers3,745
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,745
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evolution of the folding landscape of effector caspases. | J Biol Chem | 2021 | 34592312 | PubTator, text mining | PubMed |
| Network Pharmacology Integrated with Molecular Docking Explores the Mechanisms of Naringin against Osteoporotic Fracture by Regulating Oxidative Stress. | Evid Based Complement Alternat Med | 2021 | 34589132 | PubTator, text mining | PubMed |
| Potentially Functional microRNA-mRNA Regulatory Networks in Intestinal Ischemia-Reperfusion Injury: A Bioinformatics Analysis. | J Inflamm Res | 2021 | 34584440 | PubTator, text mining | PubMed |
| Disease-Dependent Antiapoptotic Effects of Cannabidiol for Keratinocytes Observed upon UV Irradiation. | Int J Mol Sci | 2021 | 34576119 | PubTator, text mining | PubMed |
| LncRNA KASRT Serves as a Potential Treatment Target by Regulating SRSF1-Related KLF6 Alternative Splicing and the P21/CCND1 Pathway in Osteosarcoma: An In Vitro and In Vivo Study. | Front Oncol | 2021 | 34568030 | PubTator, text mining | PubMed |
| Dependence receptors: new targets for cancer therapy. | EMBO Mol Med | 2021 | 34542930 | PubTator, text mining | PubMed |
| Insm1, Neurod1, and Pax6 promote murine pancreatic endocrine cell development through overlapping yet distinct RNA transcription and splicing programs. | G3 (Bethesda) | 2021 | 34534285 | PubTator, text mining | PubMed |
| Inhibiting BCKDK in triple negative breast cancer suppresses protein translation, impairs mitochondrial function, and potentiates doxorubicin cytotoxicity. | Cell Death Discov | 2021 | 34526485 | PubTator, text mining | PubMed |
| Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry. | Theranostics | 2021 | 34522211 | PubTator, text mining | PubMed |
| Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection. | Talanta | 2021 | 34517577 | PubTator, text mining | PubMed |
| Progress and challenges in understanding the regulation and function of p53 dynamics. | Biochem Soc Trans | 2021 | 34495325 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Pyroptosis, metabolism, and tumor immune microenvironment. | Clin Transl Med | 2021 | 34459122 | PubTator, text mining | PubMed |
| Hijacking of the Host's Immune Surveillance Radars by Burkholderia pseudomallei. | Front Immunol | 2021 | 34456925 | PubTator, text mining | PubMed |
| Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer. | Asian Pac J Cancer Prev | 2021 | 34452557 | PubTator, text mining | PubMed |
| The Multifaceted Role of TGF-β in Gastrointestinal Tumors. | Cancers (Basel) | 2021 | 34439114 | PubTator, text mining | PubMed |
| PROFICS: A bacterial selection system for directed evolution of proteases. | J Biol Chem | 2021 | 34418435 | PubTator, text mining | PubMed |
| Effects of intravitreal injection of siRNA against caspase-2 on retinal and optic nerve degeneration in air blast induced ocular trauma. | Sci Rep | 2021 | 34413361 | PubTator, text mining | PubMed |
| Effects of neoadjuvant therapies on genetic regulation of targeted pathways in ER+ primary ductal breast carcinoma: A meta-analysis of microarray datasets. | Saudi Pharm J | 2021 | 34400859 | PubTator, text mining | PubMed |
| Possible Mechanisms of Tau Spread and Toxicity in Alzheimer's Disease. | Front Cell Dev Biol | 2021 | 34395435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/835/papers?page=34